NR1H4 and liver disorder: Constitutively active intestinal FXR improved BA homeostasis and reduced cellular proliferation, hepatic inflammation, and fibrosis in young FXR null mice 62,63 The therapeutic indications for the use of intestinal-specific FXR modulators may also be extended to liver disorders.